Human endogenous retroviruses (HERVs) associated with glioblastoma risk and prognosis.
Saved in:
| Title: | Human endogenous retroviruses (HERVs) associated with glioblastoma risk and prognosis. |
|---|---|
| Authors: | Mazumder H; Biostatistics Program, Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA, USA., Lin HY; Biostatistics Program, Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA, USA.; Louisiana Cancer Research Center, New Orleans, LA, USA., Baddoo M; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA., Gałan W, Polania-Villanueva D; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Hicks C; Department of Genetics and the Bioinformatics and Genomics Program, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA., Otohinoyi D; Department of Genetics and the Bioinformatics and Genomics Program, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA., Peruzzi F; Louisiana Cancer Research Center, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Department of Medicine, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA., Madeja Z; Department of Cell Biology, Jagiellonian University in Kraków, Faculty of Biochemistry, Biophysics and Biotechnology, Kraków, Poland., Belancio VP; Louisiana Cancer Research Center, New Orleans, LA, USA.; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA.; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA., Flemington EK; Louisiana Cancer Research Center, New Orleans, LA, USA.; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA.; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Reiss K; Louisiana Cancer Research Center, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA., Rak M; Louisiana Cancer Research Center, New Orleans, LA, USA. mrak1@lsuhsc.edu.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. mrak1@lsuhsc.edu.; Department of Cell Biology, Jagiellonian University in Kraków, Faculty of Biochemistry, Biophysics and Biotechnology, Kraków, Poland. mrak1@lsuhsc.edu.; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA. mrak1@lsuhsc.edu. |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2025 Jun; Vol. 32 (6), pp. 622-632. Date of Electronic Publication: 2025 May 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40389618 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Human endogenous retroviruses (HERVs) associated with glioblastoma risk and prognosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mazumder+H%22">Mazumder H</searchLink>; Biostatistics Program, Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+HY%22">Lin HY</searchLink>; Biostatistics Program, Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA, USA.; Louisiana Cancer Research Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Baddoo+M%22">Baddoo M</searchLink>; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Gałan+W%22">Gałan W</searchLink><br /><searchLink fieldCode="AU" term="%22Polania-Villanueva+D%22">Polania-Villanueva D</searchLink>; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Hicks+C%22">Hicks C</searchLink>; Department of Genetics and the Bioinformatics and Genomics Program, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Otohinoyi+D%22">Otohinoyi D</searchLink>; Department of Genetics and the Bioinformatics and Genomics Program, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Peruzzi+F%22">Peruzzi F</searchLink>; Louisiana Cancer Research Center, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Department of Medicine, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Madeja+Z%22">Madeja Z</searchLink>; Department of Cell Biology, Jagiellonian University in Kraków, Faculty of Biochemistry, Biophysics and Biotechnology, Kraków, Poland.<br /><searchLink fieldCode="AU" term="%22Belancio+VP%22">Belancio VP</searchLink>; Louisiana Cancer Research Center, New Orleans, LA, USA.; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA.; Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Flemington+EK%22">Flemington EK</searchLink>; Louisiana Cancer Research Center, New Orleans, LA, USA.; Tulane Cancer Center, Tulane Health Sciences Center, New Orleans, LA, USA.; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Reiss+K%22">Reiss K</searchLink>; Louisiana Cancer Research Center, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Rak+M%22">Rak M</searchLink>; Louisiana Cancer Research Center, New Orleans, LA, USA. mrak1@lsuhsc.edu.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. mrak1@lsuhsc.edu.; Department of Cell Biology, Jagiellonian University in Kraków, Faculty of Biochemistry, Biophysics and Biotechnology, Kraków, Poland. mrak1@lsuhsc.edu.; Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA, USA. mrak1@lsuhsc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2025 Jun; Vol. 32 (6), pp. 622-632. <i>Date of Electronic Publication: </i>2025 May 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40389618 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41417-024-00868-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 622 Titles: – TitleFull: Human endogenous retroviruses (HERVs) associated with glioblastoma risk and prognosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mazumder H – PersonEntity: Name: NameFull: Lin HY – PersonEntity: Name: NameFull: Baddoo M – PersonEntity: Name: NameFull: Gałan W – PersonEntity: Name: NameFull: Polania-Villanueva D – PersonEntity: Name: NameFull: Hicks C – PersonEntity: Name: NameFull: Otohinoyi D – PersonEntity: Name: NameFull: Peruzzi F – PersonEntity: Name: NameFull: Madeja Z – PersonEntity: Name: NameFull: Belancio VP – PersonEntity: Name: NameFull: Flemington EK – PersonEntity: Name: NameFull: Reiss K – PersonEntity: Name: NameFull: Rak M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5500 Numbering: – Type: volume Value: 32 – Type: issue Value: 6 Titles: – TitleFull: Cancer gene therapy Type: main |
| ResultId | 1 |